Home / Stocks / Healthcare Glob. Ent. Ltd
HCG

Healthcare Glob. Ent. Ltd Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹614.9

Change

+15.55 (2.59%)

Open

₹595.2

Prev. Close

₹599.35

Day High

₹616.95

Day Low

₹588.8

Volume Analysis

Traded

152,279

Delivered

97,774

Delivery %

64.21%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (0)

No signal for this stock

Weaknesses (4)

  • •High debt-to-equity ratio (1.19)
  • •Low return on equity (2.54%)
  • •Promoter holding is falling
  • •Below-average fundamentals quality score (45/100)

Opportunities (0)

No signal for this stock

Threats (1)

  • •FII holding has been falling

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹653.11 ₹635.03 ₹624.96 ₹606.88 ₹596.81 ₹578.73 ₹568.66
Fibonacci ₹635.03 ₹624.28 ₹617.63 ₹606.88 ₹596.13 ₹589.48 ₹578.73
Camarilla ₹622.64 ₹620.06 ₹617.48 ₹606.88 ₹612.32 ₹609.74 ₹607.16

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-5.81%

1 Week

+6.8%

1 Month

+11.78%

3 Months

-15.3%

6 Months

-6.02%

1 Year

-17.25%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹43.23

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

1.53%

Net margin 0.81% × asset turnover 0.68x × equity multiplier 2.77x

Company Overview

Sector

Healthcare

Market Cap

₹8,562 Cr

P/E (TTM)

216.0

ROE

2.54%

Book Value

₹90.3

Face Value

₹10.0

Source: Screener.in (Consolidated figures) — data as of 17 Nov 2026. Not investment advice.

TopFund Analysis

Healthcare Glob. Ent. Ltd scores weakly on TopFund's composite fundamentals check within the Healthcare sector, at 45/100. The strongest factor is Cash Flow (72/100), while Valuation (10/100) is the weakest area to weigh before deciding. Notably: High debt-to-equity ratio (1.19); low return on equity (2.54%). FII holding has been falling.

TopFund Score — Fundamentals Quality

45/100 — Weak

Data confidence: 79/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

48

Growth

57

Valuation

10

Cash Flow

72

Corporate Governance

43

Momentum

23

Institutional Ownership

47

Business Quality

40

Risk & Volatility

58

Liquidity

66

From Screener.in

  • −Stock is trading at 6.36 times its book value
  • −Though the company is reporting repeated profits, it is not paying out dividend
  • −Company has low interest coverage ratio.
  • −Company has a low return on equity of 4.24% over last 3 years.

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Please see attached the Transcript of the Earnings Call held on November 06, 2026 with the Analysts/Investors to discuss the Unaudited Financial Results (both Standalone …

Copy of newspaper publicaiton of unaudited financial Results (standdalone and consolidated) of the company for the quarter ended September 30, 2026

Audio recording of November 6, 2026 earnings call for Q2 FY27 results uploaded on company website.

HCG reported Q2 FY27 results on 5 Nov 2026; revenue rose 16% YoY, adjusted EBITDA 17%.

Investor Presentation on the Unaudited Financial Results (Standalone and Consolidated) for the quarter and six months ended September 30, 2026.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 487 470 495 526 554 559 585 613 647 633 652 695 732
Expenses + 402 391 403 435 451 470 480 505 524 524 527 573 598
Operating Profit 85 79 92 91 102 88 106 108 123 110 125 122 133
OPM % 17.38% 16.73% 18.61% 17.3% 18.47% 15.82% 18.05% 17.58% 19.06% 17.31% 19.17% 17.59% 18.23%
Other Income + 3 6 9 9 11 6 10 8 3 -10 -18 13 -9
Interest 27 29 27 34 36 41 44 45 44 45 43 40 38
Depreciation 43 44 46 47 50 57 58 58 63 61 63 70 68
Profit before tax 18 11 28 19 28 -3 14 12 20 -6 1 25 18
Tax % 39.84% 68.99% 16.87% 28.23% 25.21% -334.85% 50.29% 49.83% -4.24% 30.15% -223.2% 34.24% 49.97%
Net Profit + 11 3 23 14 21 8 7 6 21 -8 4 16 9
EPS in Rs 1 0 2 1 1 1 1 0 1 -1 0 1 0
Raw PDF — — — — — — — — — — — — —
YoY Sales growth 16 11 12 14 14 19 18 17 17 13 11 13 13

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 519 584 700 829 976 1,092 1,009 1,395 1,691 1,908 2,218 2,538 2,712
Expenses + 443 499 595 713 864 936 887 1,161 1,394 1,581 1,835 2,080 2,222
Operating Profit 76 85 105 116 112 157 122 234 297 327 384 459 490
OPM % 15.0% 15.0% 15.0% 14.0% 11.0% 14.0% 12.0% 17.0% 18.0% 17.0% 17.0% 18.0% 18.0%
Other Income + 0 -2 10 25 10 10 -72 110 15 24 39 -11 -24
Interest 34 38 23 42 70 138 119 98 104 109 155 177 166
Depreciation 39 44 57 71 85 148 159 158 163 174 211 244 262
Profit before tax 3 0 35 27 -33 -119 -229 88 45 68 57 27 39
Tax % -56.0% -730.0% 34.0% 38.0% -7.0% 5.0% -3.0% 56.0% 61.0% 39.0% 14.0% 15.0% —
Net Profit + 5 2 23 17 -31 -125 -221 39 18 41 49 23 22
EPS in Rs 0 0 3 2 -3 -12 -15 4 2 3 3 1 1
Dividend Payout % 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% —
Sales growth 15 12 20 18 18 12 -8 38 21 13 16 14 13

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 210 341 347 428 389 293 572 731 721 686 783 1,183 1,199
Borrowings + 349 324 420 464 658 1,347 977 915 901 1,274 1,837 1,735 1,609
Other Liabilities + 147 294 372 461 515 518 357 433 549 601 780 853 772
Total Liabilities 776 1,043 1,225 1,440 1,650 2,246 2,031 2,218 2,311 2,701 3,540 3,920 3,730
Fixed Assets + 528 583 685 828 970 1,646 1,382 1,547 1,553 1,758 2,442 2,462 2,580
CWIP 42 121 148 174 153 46 30 22 18 83 25 19 24
Investments 0 64 11 53 49 34 26 9 10 10 11 14 16
Other Assets + 205 275 381 385 478 520 593 641 730 850 1,062 1,426 1,109
Total Assets 776 1,043 1,225 1,440 1,650 2,246 2,031 2,218 2,311 2,701 3,540 3,920 3,730
Equity Capital 70 85 86 87 88 89 125 139 139 139 139 149 149

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 60 73 91 98 98 130 121 220 252 285 317 347
Cash from Investing Activity + -79 -204 -210 -283 -238 -101 -171 125 -133 -226 -488 -177
Cash from Financing Activity + 22 216 89 161 84 -58 112 -155 -140 -64 -42 241
Net Cash Flow 2 85 -29 -24 -56 -30 62 190 -22 -5 -213 410
Free Cash Flow -20 -137 -101 -158 -90 23 85 150 126 101 110 59
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 87 99 93 88 121 100 68 104 92 101 91 83

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 71.29% → 64.21%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 13.89% 13.45% 13.9% 12.84% 13.07% 13.86% 22.17% 14.28% 14.71% 14.15% 13.86% 12.32%
Promoters 71.29% 71.28% 71.26% 71.23% 71.22% 71.22% 62.46% 63.78% 63.77% 64.21% 64.21% 64.21%
FII 6.37% 6.74% 3.95% 4.3% 2.77% 2.44% 2.16% 3.59% 3.22% 2.76% 2.73% 2.7%
DII 8.46% 8.52% 10.89% 11.64% 12.94% 12.48% 13.22% 18.36% 18.3% 18.91% 19.2% 20.78%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Healthcare Glob. Ent. Ltd (this stock) 8,562 216.0 6.36 2.54%
Thyrocare Tech Ltd 7,940 45.3 14.31 28.4%
Aarti Pharmalabs Limited 9,212 35.4 4.08 8.59%
Suven Life Sciences Ltd 7,850 — 17.38 -81.5%
Paras Healthcare Limited 9,284 129.0 — 13.0%
Strides Pharma Sci Ltd 9,353 16.2 2.74 20.0%
Jupiter Life Line Hosp L 9,507 50.0 5.84 13.1%

Which Mutual Funds Hold Healthcare Glob. Ent. Ltd?

Frequently Asked Questions about Healthcare Glob. Ent. Ltd

Community Sentiment

What are other investors saying about Healthcare Glob. Ent. Ltd?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.